AR026917A1 - Agentes terapeuticos - Google Patents

Agentes terapeuticos

Info

Publication number
AR026917A1
AR026917A1 ARP000106517A ARP000106517A AR026917A1 AR 026917 A1 AR026917 A1 AR 026917A1 AR P000106517 A ARP000106517 A AR P000106517A AR P000106517 A ARP000106517 A AR P000106517A AR 026917 A1 AR026917 A1 AR 026917A1
Authority
AR
Argentina
Prior art keywords
composition
nsaid
melting point
silicon dioxide
degree
Prior art date
Application number
ARP000106517A
Other languages
English (en)
Spanish (es)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929077.7A external-priority patent/GB9929077D0/en
Priority claimed from GBGB9929078.5A external-priority patent/GB9929078D0/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of AR026917A1 publication Critical patent/AR026917A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ARP000106517A 1999-12-09 2000-12-07 Agentes terapeuticos AR026917A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9929077.7A GB9929077D0 (en) 1999-12-09 1999-12-09 Therapeutic agents
GBGB9929078.5A GB9929078D0 (en) 1999-12-09 1999-12-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
AR026917A1 true AR026917A1 (es) 2003-03-05

Family

ID=26316111

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106517A AR026917A1 (es) 1999-12-09 2000-12-07 Agentes terapeuticos

Country Status (27)

Country Link
US (1) US8124124B2 (https=)
EP (1) EP1235558B1 (https=)
JP (1) JP4040878B2 (https=)
KR (1) KR20020082464A (https=)
CN (1) CN100346774C (https=)
AR (1) AR026917A1 (https=)
AT (1) ATE324868T1 (https=)
AU (1) AU776308B2 (https=)
BG (1) BG66007B1 (https=)
BR (1) BR0016236A (https=)
CA (1) CA2393585C (https=)
CY (1) CY1106136T1 (https=)
CZ (1) CZ300558B6 (https=)
DE (1) DE60027761T2 (https=)
DK (1) DK1235558T3 (https=)
ES (1) ES2263510T3 (https=)
HK (1) HK1046644B (https=)
HU (1) HU227045B1 (https=)
IL (2) IL150030A0 (https=)
MX (1) MXPA02005663A (https=)
NO (1) NO332259B1 (https=)
NZ (1) NZ519485A (https=)
PL (1) PL201223B1 (https=)
PT (1) PT1235558E (https=)
RU (1) RU2246294C2 (https=)
SK (1) SK285706B6 (https=)
WO (1) WO2001041733A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
DE602006001295D1 (de) * 2005-02-03 2008-07-03 Nycomed Pharma As Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
EP1968542B1 (en) * 2005-12-16 2013-08-14 Hanmi Science Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
EP1905427B1 (en) * 2006-09-28 2010-11-24 Losan Pharma GmbH Rapidly solubilising formulation of non-steroidal anti-inflammatory drugs
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
US8662705B2 (en) 2010-03-30 2014-03-04 Virwall Systems, Inc. Flexible ultraviolet LED sanitizing apparatus
US20130108699A1 (en) * 2010-04-26 2013-05-02 Jose Antonio Matji Tuduri Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for obtaining high dosage active substances thereof
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)
WO2013095317A2 (en) * 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
WO2013143688A1 (en) 2012-03-26 2013-10-03 Glatt Ag Taste-masked ibuprofen granules
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CZ304685B6 (cs) * 2013-12-18 2014-08-27 Technická univerzita v Liberci Způsob rozvádění příze při jejím navíjení na cívku uloženou v navíjecím ústrojí pracovního místa textilního stroje a zařízení k jeho provádění
AU2015283133B2 (en) 2014-07-02 2019-05-16 ObsEva SA Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime useful in methods of treating conditions related to the OT-R activity
US20190022013A1 (en) * 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
BE1023057B1 (nl) * 2016-06-06 2016-11-16 Nordic Specialty Pharma Bvba Ibuprofen tablet
JP6792235B2 (ja) * 2016-09-05 2020-11-25 株式会社アクロエッジ 凝集体の凝集度の測定方法及び凝集度測定装置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120616A (en) * 1980-02-27 1981-09-22 Kaken Pharmaceut Co Ltd Ibuprofen-containing granule, its preparation, and internal medicine comprising it
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
SE463541B (sv) 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
CA2076983A1 (en) 1990-04-11 1991-10-12 Robert Wu-Wei Shen Taste masking of ibuprofen by fluid bed coating
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
DK138592D0 (da) 1992-11-17 1992-11-17 Nycomed Dak As Tabletter
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
EP0758244B2 (en) * 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9702392D0 (en) * 1997-02-06 1997-03-26 Boots Co Plc Therapeutic agents
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
GB9710521D0 (en) 1997-05-22 1997-07-16 Boots Co Plc Process
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
IE980115A1 (en) * 1998-02-16 2000-02-09 Biovail Internat Ltd Solubilizing delivery systems and method of manufacture

Also Published As

Publication number Publication date
ES2263510T3 (es) 2006-12-16
HU227045B1 (en) 2010-05-28
HUP0203553A2 (hu) 2004-05-28
SK285706B6 (sk) 2007-06-07
ATE324868T1 (de) 2006-06-15
WO2001041733A2 (en) 2001-06-14
WO2001041733A3 (en) 2001-11-15
IL150030A (en) 2008-06-05
DK1235558T3 (da) 2006-10-09
HUP0203553A3 (en) 2004-06-28
NZ519485A (en) 2004-02-27
US8124124B2 (en) 2012-02-28
EP1235558A2 (en) 2002-09-04
DE60027761D1 (de) 2006-06-08
AU2004231245A1 (en) 2004-12-23
EP1235558B1 (en) 2006-05-03
HK1046644B (en) 2006-11-10
US20030203026A1 (en) 2003-10-30
AU3006001A (en) 2001-06-18
CY1106136T1 (el) 2011-06-08
CA2393585A1 (en) 2001-06-14
RU2002118210A (ru) 2004-02-20
CA2393585C (en) 2007-07-03
HK1046644A1 (en) 2003-01-24
CZ20021971A3 (cs) 2002-11-13
CZ300558B6 (cs) 2009-06-17
JP4040878B2 (ja) 2008-01-30
MXPA02005663A (es) 2002-09-02
SK8022002A3 (en) 2003-07-01
CN1433300A (zh) 2003-07-30
IL150030A0 (en) 2002-12-01
NO20022692L (no) 2002-08-07
BR0016236A (pt) 2002-12-24
KR20020082464A (ko) 2002-10-31
DE60027761T2 (de) 2007-01-25
JP2003516341A (ja) 2003-05-13
BG106839A (bg) 2003-03-31
RU2246294C2 (ru) 2005-02-20
NO20022692D0 (no) 2002-06-06
PL355491A1 (en) 2004-05-04
CN100346774C (zh) 2007-11-07
PT1235558E (pt) 2006-09-29
NO332259B1 (no) 2012-08-13
PL201223B1 (pl) 2009-03-31
BG66007B1 (bg) 2010-10-29
AU776308B2 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
AR026917A1 (es) Agentes terapeuticos
US6319520B1 (en) Solid thermoformable controlled-release pharmaceutical composition
ATE438388T1 (de) Arzneimittel zur gesteuerten freisetzung von paracetamol
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
DE69009769D1 (de) Arzneimittel mit gesteuerter wirkstoffreisetzung.
ITMI942484A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
ES2647671T3 (es) Composición de liberación rápida que incluye gránulos fundidos de un fármaco sensible a humedad y procedimiento de preparación de la misma
AR034438A1 (es) Agentes terapeuticos
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
RU2013139701A (ru) Способ контролируемой кристаллизации активного фармацевтического ингредиента из состояния переохлажденной жидкости экструзией горячего распада
MX9207495A (es) Compuestos de tetrahidroisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ATE78157T1 (de) Arzneimittel mit langsamer freisetzung.
ATE344022T1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
ES2247362T3 (es) Composiciones farmaceuticas orales con biodisponibilidad mejorada.
AR005353A1 (es) Formulacion de hormona para crecimiento animal de liberacion sostenida, y un procedimiento para la preparacion de la misma
AR034436A1 (es) Agentes terapeuticos.
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
RU2008115507A (ru) Композиция, включающая нпвс и парацетамол
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
CO5650230A2 (es) Composiciones estables de atorvastatina preparadas con granulacion en humedo
ATE552826T1 (de) Pharmazeutische formulierungen mit clopidogrel
GEP20033078B (en) Controlled-Release Compositions of Betahistine
WO2002098388A3 (en) Effervescent formulations of non-steroidal anti-inflammatory drugs
AR051589A1 (es) Agentes terapeuticos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal